Commercial insurance payors
Revenue Exposure
Profits are concentrated in higher-paying commercial payor plans; rate pressure, plan design changes, and policy shifts (e.g., charitable premium assistance restrictions) directly affect revenue and profitability.
Relevance 95·Dependency 90·Confidence 94
Source evidence
“the concentration of profits generated by higher-paying commercial payor plans for which there is continued downward pressure on average realized payment rates”
Medicare ESRD Prospective Payment System
Regulatory Exposure
Core dialysis revenue is set by the ESRD PPS bundle; rate adjustments or inadequate funding of bundle components directly affect revenues.
Relevance 95·Dependency 90·Confidence 95
Source evidence
“Any failure to adequately calculate or fund the costs associated with these items or a material reduction in reimbursement under the ESRD PPS could have a material adverse effect on our business, results of operations, financial condition and cash flows.”
Commercial payors
Revenue Exposure
Revenue materially depends on the share of higher-paying commercially insured patients and on negotiating/maintaining competitive private payor contracts.
Relevance 95·Dependency 80·Confidence 95
Source evidence
“the number or percentage of patients with higher-paying commercial insurance and our ability to negotiate and maintain contracts with private payors on competitive terms”
U.S. government healthcare programs (Medicare, Medicare Advantage, Medicaid, VA)
Revenue Exposure
Participation in Medicare, Medicare Advantage, Medicaid, and VA programs is a principal revenue-related risk; costs may increase faster than Medicare rate updates.
Relevance 95·Dependency 80·Confidence 95
Source evidence
“our participation in government healthcare programs, including Medicare, Medicare Advantage, Medicaid and the Department of Veterans Affairs”
Labor shortages and challenging labor market conditions
Cost Driver
Labor-intensive dialysis operations face cost pressure from labor supply shortages and challenging labor market conditions, plus competition for skilled clinical personnel.
Relevance 90·Dependency 75·Confidence 94
Source evidence
“labor supply shortages and other challenging labor market conditions have continued to put pressure on our existing cost structure, including among other things, staffing, labor and supply costs.”
Clinical labor shortage and wage inflation
Cost Driver
Nationwide nursing shortages and wage pressure raise labor costs that may outpace Medicare rate increases and limit expansion of IKC and kidney care services.
Relevance 90·Dependency 75·Confidence 95
Source evidence
“the ongoing nursing shortage may limit our ability to expand our operations”
ESKD/CKD population growth and demographic trends
Demand Driver
Treatment volumes and revenues depend on ESKD/CKD population growth driven by aging, immigration, diabetes/hypertension incidence, and transplant availability; elevated mortality reduces treatment volumes.
Relevance 90·Dependency 70·Confidence 93
Source evidence
“the growth and aging of the U.S. population, changing U.S. immigration levels, the availability of transplant opportunities, incidence rates for diseases that cause kidney failure such as diabetes and hypertension, or growth rates of minority populations with higher-than-average incidence rates of ESKD”
Pharmaceuticals
Supplier Dependency
DaVita depends on significant suppliers for pharmaceuticals and critical clinical products; vendor disruption or tariff-driven cost increases would impair operations including home dialysis.
Relevance 85·Dependency 80·Confidence 92
Source evidence
“suppliers of certain pharmaceuticals, administrative or other services or critical clinical products”
Clinical labor shortage
Cost Driver
Nationwide shortage of skilled clinical personnel drives elevated turnover, contract labor use, and labor cost increases.
Relevance 85·Dependency 70·Confidence 92
Source evidence
“the ongoing nationwide shortage of skilled clinical personnel”
Fresenius Medical Care
Competitive Exposure
Fresenius, DaVita's largest competitor, manufactures its own dialysis supplies and equipment, potentially giving it cost advantages over DaVita.
Relevance 85·Dependency 60·Confidence 97
Source evidence
“Some competitors, including our largest competitor, Fresenius Medical Care, also manufacture their own supplies and equipment, in addition to owning and operating outpatient dialysis centers worldwide, which may, among other things, provide cost advantages to such competitors.”
One Big Beautiful Bill Act (OBBBA) Medicaid provisions
Revenue Exposure
OBBBA work requirements, cost-sharing, and provider tax limitations could reduce Medicaid patient volumes and payments for dialysis services.
Relevance 85·Dependency 60·Confidence 90
Source evidence
“If these and other changes result in decreased patient volumes and revenue, substantially reduced Medicaid payments... it could have a material adverse impact on our business, results of operations, financial condition and/or cash flows.”
Information systems and billing infrastructure
Technology Dependency
Reliance on internal and third-party information systems and billing services; the 2025 cybersecurity incident illustrates breach and billing-cycle risk.
Relevance 80·Dependency 75·Confidence 90
Source evidence
“our ability to successfully maintain, operate or upgrade our information systems or those of third-party service providers upon which we rely”
Supplier and third-party service provider reliance
Supplier Dependency
DaVita depends on supplier/service provider relationships at cost-effective prices, access to pharmaceuticals/devices technology, and increasingly on third-party service providers; severe weather can strain supply chains.
Relevance 80·Dependency 70·Confidence 92
Source evidence
“Severe weather events or natural disasters could also strain global supply chains to the extent such events result in equipment and clinical supply shortages, disruptions, delays or associated price increases.”
Cybersecurity and data privacy
Regulatory Exposure
Operations depend on secure processing of PHI and other sensitive data, including reliance on critical IT vendors; breaches including state-sponsored attacks could materially harm the business.
Relevance 80·Dependency 65·Confidence 90
Source evidence
“coordinated attacks by a variety of actors, including, among others, activist entities or state sponsored cyberattacks”
Integrated Kidney Care / value-based care
Demand Driver
IKC/VBC growth strategy depends on actuarially sound payor contracts, CMMI/CKCC model continuation, and reducing total cost of care; company bears total-cost financial accountability.
Relevance 80·Dependency 50·Confidence 90
Source evidence
“we have made significant investments in our participation in the CKCC program payment model and there is no assurance that this program will be extended or modified in the future”
Patient mortality and admissions trends
Demand Driver
Elevated mortality relative to pre-pandemic periods and admissions levels drive treatment volume, expected approximately flat in 2026.
Relevance 75·Dependency 60·Confidence 90
Source evidence
“mortality levels that remain elevated relative to pre-pandemic periods, but assuming a slight improvement in flu impact compared to 2025”
Home-based dialysis (home hemodialysis and peritoneal dialysis)
Supplier Dependency
Home dialysis growth strategy is exposed to limited supplier availability for critical supplies and evolving market competition with relative ease of entry.
Relevance 75·Dependency 60·Confidence 90
Source evidence
“This developing market may create additional opportunities for competition with relative ease of entry”
U.S. Department of Veterans Affairs
Customer Exposure
Dialysis services provided to VA under NDSC with Medicare PPS-linked pricing and short-notice termination right; loss could force center closures.
Relevance 75·Dependency 55·Confidence 90
Source evidence
“Should the VA not renew or cancel our current contract for any reason... we may be required to cease accepting patients under this program and may be forced to close centers or experience lower reimbursement rates”
California AB 290 (charitable premium assistance reimbursement cap)
Regulatory Exposure
AB 290 would cap reimbursement for commercially insured patients receiving charitable premium assistance; implementation stayed pending appeal, but passage of similar state initiatives could materially harm results.
Relevance 70·Dependency 55·Confidence 92
Source evidence
“There have been several state-based policy initiatives to limit payments to dialysis providers or impose other burdensome operational requirements, which, if passed, could have a material adverse impact on our business, results of operation, financial condition and cash flows.”
Trade policies and tariffs
Cost Driver
Evolving trade policies and tariffs may increase cost of supplies and disrupt availability of clinical supplies, including for home dialysis.
Relevance 65·Dependency 55·Confidence 88
Source evidence
“the impact of evolving trade policies and tariffs and any reduction in clinical and other supplies due to any disruptions experienced by third party vendors”